Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
Intervention1: VIRECHANA: Group A patients will be administered Virechana drug using Trivruta Avaleha 80 to 100 gm followed by Vasadi Churna 3 gm 6 hourly during bleeding 3 gm bd after bleeding orally
Sponsors
IPGT AND RA GAU JAMNAGAR
Eligibility
Inclusion criteria
Inclusion criteria: Patients having any one or two of the following features will be included Ayurvedic features of Asrigdara Modern features Excessive bleeding Prolonged duration Intermenstrual bleeding Bleedinng due to other cause Patients who are Yogya for Virechana The quantity of bleeding will be decided by complete soaked number of pads and using thickened pads
Exclusion criteria
Exclusion criteria: Age below 18 and above 50 years Bleeding due to Erosion cancer fibroid and Polyp Bleeding followed by abortion Bleeding from the site other than the uterus Coagulation disorders Suffering from malignancies and chronic systemic diseases like, uncontrolled hypertension (Systolic blood pressure above 180 & Diastolic blood pressure above 120mmhg) uncontrolled diabetes (above the range of 160-200 mg/dl (RBS) Veneral disease Patients who are Ayogya for Virechana Post menopausal bleeding Hb% <7
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cure of asrigdaraTimepoint: 4 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Relief in bleeding as compare to previousTimepoint: 4 month | — |
Countries
India
Contacts
Public ContactPROF LAXMIPRIYA DEI
IPGT AND RA GAU JAMNAGAR
Outcome results
None listed